All Stories

  1. Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer
  2. Impact of cetuximab in current treatment of metastatic colorectal cancer
  3. Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer
  4. Role of cetuximab in first-line treatment of metastatic colorectal cancer